|
Loading...
| ||||||||||||||
Recent Publications by AstraZeneca R&D: |  | |
| Molybdenum-Mediated Carbonylation of Aryl Halides with Nucleophiles Using Microwave Irradiation.
A new, efficient, and practical molybdenum-mediated carbonylation of aryl... | Department of Chemistry, AstraZeneca R&D Charnwood, Bakewell Road, | Org Lett. 2010 Aug 26.
DOI Direct Link |
| Observed peptide pI and retention time shifts as a result of post-translational modifications in multidimensional separations using narrow-range IPG-IEF.
Modified peptides constitute a sub-population among the tryptic peptides... | Department of Safety Assessment, Molecular Toxicology, AstraZeneca R&D, | Amino Acids. 2010 Aug 20.
DOI Direct Link |
| Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective.
Innovation is essential for the identification of novel pharmacological... | CNS & Pain Discovery Research, AstraZeneca Pharmaceuticals, Wilmington, | Int J Neuropsychopharmacol. 2010 Aug 18:1-16.
DOI Direct Link |
| Practical synthesis of quinoxalinones via palladium-catalyzed intramolecular N-arylations.
A practical and highly efficient route to the synthesis of... | Department of Medicinal Chemistry, AstraZeneca R&D Montreal, 7171 | Org Lett. 2010 Aug 20;12(16):3574-7.
DOI Direct Link |
| A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain.
Cannabinoids are analgesic in man, but their use is limited by their... | AstraZeneca R&D Montreal, 7171 Frederick-Banting, Ville Saint-Laurent, | Pain. 2010 Aug 7.
DOI Direct Link |